Secure Adoption

Secure adoption of technology that has been developed

Assess enables Innovators to quantify the procurement case for their market ready technologies, using robust health economic modelling incorporating trial and real world data, to characterize impact on health outcomes, resource use, budget impact and system efficiency.

Learn more
How We Do It

Analytic approach to informing technology adoption decisions

A global network of experts bring methods and insights from health technology assessment and economic modelling to help innovative companies demonstrate their Procurement Case, and that their technology represents good value for health care resources and should be procured and adopted into care pathways.

Economic Analysis of Trial Data

Data collected from trial can be analyzed to demonstrate the economic value of technology when implemented into care pathways.

This analysis supports decision makers to understand technology impact on:

  • Healthcare resource utilization/costs
  • Health-related quality of life
  • Health care budgets over time

Analysis of trial data can determine whether a technology is considered cost-effective, and inform its value-based price.

Market Segmentation Patient Target Calculation Market Sizing
team
Photo by UX Indonesia on Unsplash

Health Economic Payer Submission

Submission of dossiers to payers for them to consider procurement requires analyses and evidence on the economic impact of health care technology for the proposed technology usage.

Submission packages can be prepared to describe the evidence for technology cost-effectiveness, and include a budget impact analysis to inform decision-making.

  • Trial Objectives
  • Implementation Strategies
  • Study Design
  • Outcome Measures

Real World Evidence (RWE) Development Plan

It in increasingly common that data collected from trial of technology is not able to eliminate uncertainty about how the technology will perform in routine clinical practice.

Payers increasingly are interested in on-market data collection that represents the outcomes achieved with technology use in real world settings.

An RWE Development Plan describes when and how data is to be collected, how it will be analyzed, and what decisions will be made on the basis of the results. The Plan:

  • Can permit procurement despite remaining uncertainty
  • Reduces risk for payers with pre-specified data collection/analysis and decisions that will be made
  • Improves ability to report on the economic value of technology in routine practice, supporting scale and spread
Market Segmentation Patient Target Calculation Market Sizing
Testimonials

What our clients say

“The ASSESS project provided NURA with robust, real-world data to substantiate the health economic rationale underlying our pricing structure. This data will be instrumental in presenting our value proposition to hospital decision-makers and investors.”

Georgia Powell
Co-founder & CEO

“The economic modeling report is a foundational tool that supports our firm’s growth by providing data-driven insights for investors, internal decision-makers, and potential clients. I am highly satisfied and would recommend the service to other firms.”

Cindy Sim
CEO

“The economic evaluation that was conducted helped with initial conversations with our investors and it ultimately led to the closure of our first financing round.

The model conducted by the ASSESS team also really gave my team and I a great starting point to truly understand the complete economics behind the problem we are solving and what types of clinical studies that we need to build in order to demonstrate the economic value proposition of the technology.”

Saumik Biswas
CEO, Founder

“We are extremely satisfied with the work done and have already recommended the service to others.

This program has been invaluable to us, I can't say enough to recommend it - this kind of evidence is vital to digital health sales and incredibly hard to find. We plan to include the service in major research projects in the future to demonstrate the economic impact of our interventions.”

Rob Attwell
COO

Contact Us

Contact us to learn more about how insights from ASSESS can help your organization to secure technology adoption in target health systems.

Let's talk